Inventor · disambiguated record
Harald Engelhardt
Also filed as: ENGELHARDT HARALD
24 granted patents·16 pending applications·270 citations·filing 2005–2024
95Inventor score
Files withBOEHRINGER INGELHEIM INT25ENGELHARDT HARALD10MCCONNELL DARRYL1SMETHURST CHRISTIAN1STADTMUELLER HEINZ1
Top patents by PatentIndex Score
40 records- 0196US7371753B2Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2005·Granted May 13, 2008·77 cites·10 claims
- 0296US7241769B2Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jul 10, 2007·71 cites·13 claims
- 0394US10328074B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Jun 25, 2019·26 cites·25 claims
- 0492US7521457B2Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Apr 21, 2009·27 cites·11 claims
- 0588US8258129B24-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicamentsENGELHARDT HARALD·Filed 2007·Granted Sep 4, 2012·11 cites·3 claims
- 0686US7569561B22,4-diaminopyrimidines useful for treating cell proliferation diseasesBOEHRINGER INGELHEIM INT·Filed 2007·Granted Aug 4, 2009·11 cites·8 claims
- 0783US8895581B21H-imidazo[4,5-c]quinolinesMCCONNELL DARRYL·Filed 2011·Granted Nov 25, 2014·12 cites·18 claims
- 0881US8575203B2Chemical compoundsENGELHARDT HARALD·Filed 2011·Granted Nov 5, 2013·7 cites·11 claims
- 0981US8207179B2Substituted indolines as tyrosine kinase inhibitorsENGELHARDT HARALD·Filed 2008·Granted Jun 26, 2012·8 cites·4 claims
- 1079US9199988B2Dihydroquinazolinone analoguesSMETHURST CHRISTIAN·Filed 2014·Granted Dec 1, 2015·4 cites·9 claims
- 1178US9428513B2TriazolopyrazineBOEHRINGER INGELHEIM INT·Filed 2014·Granted Aug 30, 2016·2 cites·16 claims
- 1278US8637549B2Pyridons as PDK1 inhibitorsENGELHARDT HARALD·Filed 2009·Granted Jan 28, 2014·4 cites·17 claims
- 1377US9102684B2Indolinone analoguesENGELHARDT HARALD·Filed 2014·Granted Aug 11, 2015·2 cites·14 claims
- 1476US9428515B2Benzimidazole derivativesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Aug 30, 2016·2 cites·12 claims
- 1574US11077107B2TriazolopyrazineBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 3, 2021·0 cites·66 claims
- 1674US9296748B2PyridinonesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Mar 29, 2016·2 cites·18 claims
- 1774US9266891B2Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitorsENGELHARDT HARALD·Filed 2013·Granted Feb 23, 2016·2 cites·27 claims
- 1872US2025122204A1[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1970US9422290B2TriazolopyridazineENGELHARDT HARALD·Filed 2013·Granted Aug 23, 2016·2 cites·17 claims
- 2070US2024358688A1Substituted 1h-pyrazolo[4,3-c]pyridines and derivatives as egfr inhibitorsBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2166US2023374021A1[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2264US2009163465A1Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 2364US2009149438A1Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 2463US12064421B2Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Aug 20, 2024·0 cites·23 claims
- 2562US11608343B2Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Mar 21, 2023·0 cites·34 claims
- 2653US2011313156A1Heterocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitorsENGELHARDT HARALD·Filed 2009·Application pending·0 cites
- 2752US2011086842A1Pyrimidines as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 2852US2007032514A12,4-diamino-pyrimidines as aurora inhibitorsZAHN STEPHAN K·Filed 2006·Application pending·0 cites
- 2951US2011201608A1Substituted naphthyridines and use thereof as medicinesBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 3049US2015051208A1PyridinonesENGELHARDT HARALD·Filed 2014·Application pending·0 cites
- 3148US2011251174A12,4-diamino-pyrimidines as aurora inhibitorsBOEHRINGER INGELHEIM INT·Filed 2011·Application pending·0 cites
- 3248US2013281429A12,4-diamino-pyrimidines as aurora inhibitorsZAHN STEPHAN KARL·Filed 2013·Application pending·0 cites
- 3346US11174245B2Benzimidazole compounds and derivatives as EGFR inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Nov 16, 2021·0 cites·23 claims
- 3446US2023126204A1[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 3546US2023131720A1[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 3645US2009306067A12, 4-diaminopyrimidide derivates and their use for the treatment of cancerENGELHARDT HARALD·Filed 2007·Application pending·0 cites
- 3744US8404674B2Substituted 9H-purin-2-YL compounds, compositions thereof and uses thereofSTADTMUELLER HEINZ·Filed 2008·Granted Mar 26, 2013·0 cites·11 claims
- 3843US11261184B2[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Mar 1, 2022·0 cites·16 claims
- 3942US2006047118A1New pteridinones as PLK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 4039US11213520B2Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jan 4, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Harald Engelhardt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →